We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+2.31%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$720M
AUM Growth
-$214M
Cap. Flow
-$176M
Cap. Flow %
-24.45%
Top 10 Hldgs %
53.82%
Holding
93
New
36
Increased
15
Reduced
13
Closed
19

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$16.4M
2
BIIB icon
Biogen
BIIB
+$11.8M
3
ADBE icon
Adobe
ADBE
+$11M
4
PANW icon
Palo Alto Networks
PANW
+$10.9M
5
KRNT icon
Kornit Digital
KRNT
+$9.29M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$32.5M
2
FIVN icon
FIVE9
FIVN
+$12.8M
3
ALT icon
Altimmune
ALT
+$11.7M
4
NICE icon
Nice
NICE
+$10.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 66.02%
2 Technology 7.17%
3 Industrials 1.19%
4 Consumer Discretionary 1.16%
5 Communication Services 1.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOWL icon
51
Werewolf Therapeutics
HOWL
$17.2M
$2.83M 0.39%
626,810
+29,807
+5% +$162K
RIGL icon
52
Rigel Pharmaceuticals
RIGL
$681M
$2.55M 0.35%
216,259
-36,241
-14% -$490K
PMVP icon
53
PMV Pharmaceuticals
PMVP
$59.2M
$2.23M 0.31%
187,800
– –
STOK icon
54
Stoke Therapeutics
STOK
$1.8B
$2.02M 0.28%
+157,200
New +$2.51M
RUN icon
55
Sunrun
RUN
$2.34B
$1.79M 0.25%
+65,000
New +$2.02M
INFI
56
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.76M 0.24%
+1,476,000
New +$1.59M
ALPN
57
DELISTED
Alpine Immune Sciences Inc
ALPN
$1.44M 0.2%
+200,000
New +$1.65M
ALT icon
58
PUT
Altimmune
ALT
$552M
$1.28M 0.18%
+100,000
New +$1.48M
MGIC
59
DELISTED
Magic Software Enterprises
MGIC
$1.26M 0.18%
81,293
– –
VRNA
60
DELISTED
Verona Pharma
VRNA
$1.23M 0.17%
+120,000
New +$1.01M
PSTX
61
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$1.06M 0.15%
+300,000
New +$992K
MDWD icon
62
MediWound
MDWD
$181M
$958K 0.13%
+98,388
New +$1.24M
ICL icon
63
ICL Group
ICL
$6.53B
$912K 0.13%
+111,482
New +$1.04M
NICE icon
64
Nice
NICE
$5.79B
$592K 0.08%
3,145
-52,337
-94% -$10.9M
EWTX icon
65
Edgewise Therapeutics
EWTX
$4.13B
$590K 0.08%
+60,000
New +$606K
ONCR
66
DELISTED
Oncorus, Inc.
ONCR
$459K 0.06%
540,258
– –
U icon
67
Unity
U
$13.8B
$366K 0.05%
+11,500
New +$473K
BGMS
68
Bio Green Med Solution Inc
BGMS
$4.91M
$365K 0.05%
+69
New +$351K
IMTXW
69
DELISTED
Immatics N.V. Warrants
IMTXW
$271K 0.04%
100,000
– –
ARBE icon
70
Arbe Robotics
ARBE
$80.3M
$259K 0.04%
43,165
– –
OTMO
71
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
$111K 0.02%
26,124
– –
ABNB icon
72
Airbnb
ABNB
$89.9B
– –
-27,700
Closed -$2.47M
ALNY icon
73
CALL
Alnylam Pharmaceuticals
ALNY
$27.5B
– –
-75,000
Closed -$10.9M
AMD icon
74
Advanced Micro Devices
AMD
$776B
– –
-15,773
Closed -$1.21M
CCCC icon
75
C4 Therapeutics
CCCC
$385M
– –
-705,736
Closed -$5.32M
1 2
3
4

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q3 2022 Portfolio in Review

As of Q3 2022, Sphera Funds Management held 93 positions worth $720M, down 23% from $935M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Sphera Funds Management withdrew a net $176M in Q3 2022, closing 19 positions and reducing 13 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $32.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, up from 47% a quarter earlier, followed by Technology and Industrials.

Against the trend, Sphera Funds Management opened a new position in Biogen worth $14.8M.

  • Sphera Funds Management's largest Q3 2022 buy was Biogen: 55,500 shares worth $14.8M.
  • Sphera Funds Management added most to Sanofi in Q3 2022, an estimated $16.4M increase.
  • Sphera Funds Management's biggest Q3 2022 reduction was Altimmune, cutting an estimated $11.7M.
  • Sphera Funds Management fully exited State Street SPDR S&P Biotech ETF in Q3 2022, selling an estimated $32.5M.
  • Sphera Funds Management's ten largest holdings make up 54% of its $720M portfolio in Q3 2022.
  • Sphera Funds Management opened 36 new positions and closed 19 in Q3 2022.
  • Sphera Funds Management's portfolio value fell 23% quarter-over-quarter to $720M.

Based on Sphera Funds Management's 13F filing for Q3 2022, filed 14 Nov 2022.